M
Michael L. Birnbaum
Researcher at The Feinstein Institute for Medical Research
Publications - 55
Citations - 1989
Michael L. Birnbaum is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Mental health & Social media. The author has an hindex of 19, co-authored 44 publications receiving 1270 citations. Previous affiliations of Michael L. Birnbaum include University of Toronto & Hofstra University.
Papers
More filters
Journal ArticleDOI
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D. Howes,Robert A. McCutcheon,Ofer Agid,Andrea de Bartolomeis,Nico J.M. van Beveren,Michael L. Birnbaum,Michael A P Bloomfield,Rodrigo A. Bressan,Robert W. Buchanan,William T. Carpenter,David J. Castle,Leslie Citrome,Zafiris J. Daskalakis,Michael Davidson,Richard J. Drake,Serdar M. Dursun,Bjørn H Ebdrup,Helio Elkis,Peter Falkai,W. Wolfgang Fleischacker,Ary Gadelha,Fiona Gaughran,B. Glenthøj,Ariel Graff-Guerrero,Jaime Eduardo Cecílio Hallak,William G. Honer,James L. Kennedy,Bruce J. Kinon,Stephen M. Lawrie,Jimmy Lee,F. Markus Leweke,James H. MacCabe,Carolyn B. McNabb,Herbert Y. Meltzer,Hans-Jürgen Möller,Shinchiro Nakajima,Christos Pantelis,Tiago Reis Marques,Gary Remington,Susan L. Rossell,Bruce R. Russell,Cynthia Siu,Takefumi Suzuki,Iris E. C. Sommer,David Taylor,Neil Thomas,Alp Üçok,Daniel Umbricht,James T.R. Walters,John M. Kane,Christoph U. Correll +50 more
TL;DR: The authors present consensus guidelines that operationalize criteria for determining and reporting treatment resistance, adequate treatment, and treatment response, providing a benchmark for research and clinical translation in schizophrenia.
Journal ArticleDOI
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.
Christoph U. Correll,Jose M. Rubio,Gabriella Inczedy-Farkas,Michael L. Birnbaum,John M. Kane,Stefan Leucht +5 more
TL;DR: Higher-quality trials and patient-based meta-analyses are needed to determine whether subpopulations might benefit from combination treatment, as no single strategy can be recommended for patients with schizophrenia based on the current meta-analytic literature.
Proceedings ArticleDOI
A Taxonomy of Ethical Tensions in Inferring Mental Health States from Social Media
Stevie Chancellor,Michael L. Birnbaum,Eric D. Caine,Vincent M. B. Silenzio,Munmun De Choudhury +4 more
TL;DR: A taxonomy of concerns and ethical challenges surrounding ethics committees and the gap of social media research; questions of validity, data, and machine learning; and implications of this research for key stakeholders is presented.
Journal ArticleDOI
A Collaborative Approach to Identifying Social Media Markers of Schizophrenia by Employing Machine Learning and Clinical Appraisals
Michael L. Birnbaum,Michael L. Birnbaum,Sindhu Kiranmai Ernala,Asra F. Rizvi,Munmun De Choudhury,John M. Kane,John M. Kane +6 more
TL;DR: These data reinforce the need for ongoing collaborations integrating expertise from multiple fields to strengthen the ability to accurately identify and effectively engage individuals with mental illness online and move from noisy self-reports of schizophrenia on social media to more accurate identification of diagnoses by exploring a human-machine partnered approach.
Journal ArticleDOI
Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders.
Michael L. Birnbaum,Michael L. Birnbaum,Asra F. Rizvi,Christoph U. Correll,Christoph U. Correll,John M. Kane,John M. Kane +6 more
TL;DR: This work examined how youth with psychotic spectrum disorders versus non‐psychotic mood disorders use online resources in the early illness stages.